Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-13 Option Award |
2025-01-14 6:57 pm |
2025-01-14 2035-01-12 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO |
20,000 | $0 | 20,000 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-05 9:01 pm |
N/A 2034-01-03 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-05 4:06 pm |
N/A 2033-01-02 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-07 8:04 pm |
N/A 2032-06-30 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, CDO |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:22 pm |
N/A 2032-01-02 |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, Development |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-08-17 Conversion |
2021-08-17 12:39 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, Development |
52,439 | $0 | 27,560 (Indirect) |
View |
Ownership |
2021-08-12 7:31 pm |
N/A N/A |
Dermata Therapeutics Inc. | DRMA | Nardo Christopher J. Senior VP, Development |
0 | $0 | 140,119 (Direct) |
View |